Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search

Other Treatment

Citations 51-60 of 60 total displayed.

Past content (since Aug 2001):

Articles
Reversal of Chronic Molecular and Cellular Abnormalities Due to Heart Failure by Passive Mechanical Ventricular Containment
Hani N. Sabbah, Victor G. Sharov, Ramesh C. Gupta, Sudhish Mishra, Sharad Rastogi, Albertas I. Undrovinas, Pervaiz A. Chaudhry, Anastassia Todor, Takayuki Mishima, Elaine J. Tanhehco, and George Suzuki
Circ. Res. published October 16, 2003, doi:10.1161/01.RES.0000101932.70443.FE [Abstract]  

Molecular Medicine
Lovastatin Enhances Ecto-5'-Nucleotidase Activity and Cell Surface Expression in Endothelial Cells: Implication of Rho-Family GTPases
S. Ledoux, D. Laouari, M. Essig, I. Runembert, G. Trugnan, J.B. Michel, and G. Friedlander
Circ. Res. 2002;90:420-427; published online before print as doi:10.1161/hh0402.105668 [Abstract] [Full text]  

UltraRapid Communications
Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces
Tatsuya Shimizu, Masayuki Yamato, Yuki Isoi, Takumitsu Akutsu, Takeshi Setomaru, Kazuhiko Abe, Akihiko Kikuchi, Mitsuo Umezu, and Teruo Okano
Circ. Res. 2002;90:e40-48e; published online before print as doi:10.1161/hh0302.105722 [Abstract] [Full text]  

Articles
Lovastatin Enhances Ecto-5'-Nucleotidase Activity and Cell Surface Expression in Endothelial Cells. Implication of Rho-Family GTPases
S. Ledoux, D. Laouari, M. Essig, I. Runembert, G. Trugnan, J. B. Michel, and G. Friedlander
Circ. Res. published January 24, 2002, doi:10.1161/hh0402.105668 [Abstract]  

UltraRapid Communications
Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces
Tatsuya Shimizu, Masayuki Yamato, Yuki Isoi, Takumitsu Akutsu, Takeshi Setomaru, Kazuhiko Abe, Akihiko Kikuchi, Mitsuo Umezu, and Teruo Okano
Circ. Res. published January 24, 2002, doi:10.1161/hh0302.105722 [Abstract]  

Reviews
Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric Oxide: An Overview
Louis J. Ignarro, Claudio Napoli, and Joseph Loscalzo
Circ. Res. 2002;90:21-28, doi:10.1161/hh0102.102330 [Abstract] [Full text]  

Integrative Physiology
Fc Receptor–Mediated Inhibitory Effect of Immunoglobulin Therapy on Autoimmune Giant Cell Myocarditis: Concomitant Suppression of the Expression of Dendritic Cells
Keisuke Shioji, Chiharu Kishimoto, and Shigetake Sasayama
Circ. Res. 2001;89:540-546; published online before print as doi:10.1161/hh1801.096263 [Abstract] [Full text]  

Articles
Fc Receptor–Mediated Inhibitory Effect of Immunoglobulin Therapy on Autoimmune Giant Cell Myocarditis: Concomitant Suppression of the Expression of Dendritic Cells
Keisuke Shioji, Chiharu Kishimoto, and Shigetake Sasayama
Circ. Res. published August 30, 2001, doi:10.1161/hh1801.096263 [Abstract] [Full text]  

Reviews
Matrix Metalloproteinase Inhibition After Myocardial Infarction: A New Approach to Prevent Heart Failure?
Esther E.J.M. Creemers, Jack P.M. Cleutjens, Jos F.M. Smits, and Mat J.A.P. Daemen
Circ. Res. 2001;89:201-210, doi:10.1161/hh1501.094396 [Abstract] [Full text]  

Integrative Physiology
Acetylcholine, Bradykinin, Opioids, and Phenylephrine, but not Adenosine, Trigger Preconditioning by Generating Free Radicals and Opening Mitochondrial KATP Channels
Michael V. Cohen, Xi-Ming Yang, Guang S. Liu, Gerd Heusch, and James M. Downey
Circ. Res. 2001;89:273-278; published online before print as doi:10.1161/hh1501.094266 [Abstract] [Full text]  

[First page]   [Previous page]  
Pages: 1 2 3 4 5 6

* Subspecialty Collections Home

* Show  Other Treatment
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment